| IMGT/mAb-DB ID | 278 |
|---|
| INN (International Nonproprietary Name) | bifarcept |
|---|---|
| INN number | 8109 |
| INN proposed list | 86 () |
| INN recommended list | 48 () |
| Common name | |
| Proprietary name |
| IMGT receptor type | RPI |
|---|---|
| Species | Homo sapiens |
| FPIA, RPI or CPCA chain identification | IFNAR2 (interferon alpha/beta receptor 2, IFNABR) |
| Conjugated/ Radiolabelled | |
| Origin clone species | |
| Origin clone name | |
| IMGT/2Dstructure-DB | |
| IMGT/3Dstructure-DB |
| Specificity target name [species] |
bispecific,
[Homo sapiens]
IFNA1, [Homo sapiens] IFNB1, [Homo sapiens] |
|---|---|
| Development technology | |
| Biosimilars |
| Clinical indication | Unknown |
|---|---|
| Clinical domain | Unknown |
| Application | |
| Expression system | |
| Company | Unknown |
| Development status | |
| Regulatory agency status and year |
| Clinical Trials | 0 studies found, 0 recruiting |
|---|---|
| FDA / EMA / NCI number or ATC code |